Literature DB >> 20549860

Multiple sclerosis: axonal loss linked to MS disability.

.   

Abstract

Entities:  

Year:  2010        PMID： 20549860     DOI： 10.1038/nrneurol.2010.63

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.

Authors:  Emma C Tallantyre; Lars Bø; Omar Al-Rawashdeh; Trudy Owens; Chris H Polman; James S Lowe; Nikos Evangelou
Journal:  Mult Scler       Date:  2010-03-09       Impact factor: 6.312
  1 in total
  3 in total

1.  Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy.

Authors:  Laia Morató; Jorge Galino; Montserrat Ruiz; Noel Ylagan Calingasan; Anatoly A Starkov; Magali Dumont; Alba Naudí; Juan José Martínez; Patrick Aubourg; Manuel Portero-Otín; Reinald Pamplona; Elena Galea; M Flint Beal; Isidre Ferrer; Stéphane Fourcade; Aurora Pujol
Journal:  Brain       Date:  2013-06-22       Impact factor: 13.501

2.  Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy.

Authors:  Jone López-Erauskin; Stéphane Fourcade; Jorge Galino; Montserrat Ruiz; Agatha Schlüter; Alba Naudi; Mariona Jove; Manuel Portero-Otin; Reinald Pamplona; Isidre Ferrer; Aurora Pujol
Journal:  Ann Neurol       Date:  2011-07       Impact factor: 10.422

3.  Loss of SIRT2 leads to axonal degeneration and locomotor disability associated with redox and energy imbalance.

Authors:  Stéphane Fourcade; Laia Morató; Janani Parameswaran; Montserrat Ruiz; Tatiana Ruiz-Cortés; Mariona Jové; Alba Naudí; Paloma Martínez-Redondo; Mara Dierssen; Isidre Ferrer; Francesc Villarroya; Reinald Pamplona; Alejandro Vaquero; Manel Portero-Otín; Aurora Pujol
Journal:  Aging Cell       Date:  2017-10-05       Impact factor: 9.304
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.